Gut bacteria-metabolized equol shows promise in cancer prevention

FHS
July 11, 2024
5:27 am

Researchers reviewed how soy isoflavones are metabolized by gut bacteria into equol, exploring its role in cancer prevention and treatment. They examined the molecular mechanisms and gut microbiota involved to understand equol’s anti-tumor effects.

Editas trades part of Vertex CRISPR therapy licencing rights deal for $57m – Pharmaceutical Technology

CRISPR/Cas9 is a gene-editing technology that allows scientists to precisely cut and modify DNA in living organisms. Credit: Prostock-studio via Shutterstock. Amidst the long-running Cas9

October 6, 2024

Underweight, but Not Obesity, Linked to Glaucoma Progression

A higher body mass index (BMI) was significantly associated with slower rates of retinal nerve fiber layer change among patients with glaucoma, while those with

April 23, 2024

J&J expects strong procedure volumes in 2024

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q4 MedTech sales: $7.67

January 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.